ArticleThoracic cancer2025

Real-World Evidence That Non-Smokers With High PD-L1 Non-Squamous NSCLC Have Poorer Outcomes With Immune Checkpoint Inhibitors.

Yu-Chu Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.